How should the Madopar (Levodopa/Benserazide) dose be managed for a patient undergoing DSA under GA when the usual dosing schedule is disrupted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Perioperative Management of Madopar for DSA Under General Anesthesia

Give the 4pm dose of Madopar now (at 2:50pm) before the patient goes for DSA, as levodopa should be continued up until the time of anesthesia when the patient can still take oral medications. 1

Rationale for Continuing Madopar

  • The FDA label explicitly states that levodopa/carbidopa (and by extension levodopa/benserazide formulations like Madopar) may be continued as long as the patient is permitted to take fluids and medication by mouth when general anesthesia is required 1

  • Abrupt discontinuation or significant dose reduction of levodopa carries serious risks, including the development of neuroleptic malignant syndrome (NMS)-like symptoms with hyperpyrexia and confusion 1

  • DSA (digital subtraction angiography) is typically a relatively short procedure, and the patient will likely be able to resume oral intake within hours postoperatively 1

Practical Implementation

  • Administer the Madopar dose immediately (at 2:50pm, approximately 1 hour early) rather than waiting until 4pm, since the patient will be taken to the procedure in 10 minutes 1

  • Giving the dose 1 hour early is preferable to missing it entirely, as maintaining therapeutic levodopa levels is critical to prevent acute parkinsonian deterioration 1

  • The standard Madopar formulation reaches peak plasma levels within 1-3 hours, so administering at 2:50pm will provide therapeutic coverage during and immediately after the procedure 2

Postoperative Resumption

  • Resume the usual Madopar dosing schedule as soon as the patient is able to take oral medications postoperatively 1

  • If there is any delay in resuming oral intake, observe the patient carefully for symptoms resembling NMS, including rigidity, altered consciousness, and autonomic instability 1

  • The usual daily dosage should be administered as soon as oral medication is feasible 1

Critical Pitfall to Avoid

  • Never abruptly discontinue or significantly delay levodopa doses in Parkinson's disease patients, as this can precipitate a life-threatening NMS-like syndrome with severe rigidity, hyperthermia, and altered mental status 1

  • The risk of acute parkinsonian crisis from missing doses far outweighs any theoretical anesthetic concerns for a short procedure like DSA 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.